Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B?

× No keyword cloud information.

22 in total

Review 1. Present and future therapies of hepatitis B: From discovery to cure.

Authors: T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal: Hepatology Date: 2015-10-27 Impact factor: 17.425

Review 2. Antiviral therapies and prospects for a cure of chronic hepatitis B.

Authors: Fabien Zoulim; David Durantel
Journal: Cold Spring Harb Perspect Med Date: 2015-04-01 Impact factor: 6.915

3. Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study.

Authors: Di Wu; Peng Wang; Meifang Han; Yongping Chen; Xinyue Chen; Qi Xia; Weiming Yan; Xiaoyang Wan; Chuanlong Zhu; Qing Xie; Jiaji Jiang; Lai Wei; Deming Tan; Xiaoguang Dou; Yanyan Yu; Jinlin Hou; Xiaoping Luo; Qin Ning
Journal: Hepatol Int Date: 2019-06-06 Impact factor: 6.047

4. Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients.

Authors: X Pang; L Zhang; N Liu; B Liu; Z Chen; H Li; M Chen; M Peng; H Ren; P Hu
Journal: Clin Exp Immunol Date: 2020-07-24 Impact factor: 4.330

Review 5. The current status and future directions of hepatitis B antiviral drug discovery.

Authors: Liudi Tang; Qiong Zhao; Shuo Wu; Junjun Cheng; Jinhong Chang; Ju-Tao Guo
Journal: Expert Opin Drug Discov Date: 2016-11-11 Impact factor: 6.098

6. Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment.

Authors: Guo-Jun Li; Yi-Qi Yu; Shao-Long Chen; Ping Fan; Ling-Yun Shao; Jia-Zhen Chen; Chang-Shui Li; Bin Yi; Wei-Cun Chen; Shu-Yuan Xie; Xiao-Na Mao; He-Hui Zou; Wen-Hong Zhang
Journal: Antimicrob Agents Chemother Date: 2015-05-04 Impact factor: 5.191

7. Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial.

Authors: Ying Zhou; Rong Yan; Guo Qing Ru; Li Li Yu; Jiong Yao; Hong Wang
Journal: Hepatol Int Date: 2019-06-06 Impact factor: 9.029

Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B?